Compass Therapeutics, Inc.

Direct answer

Compass Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CMPX.

Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand...

Can you invest in Compass Therapeutics, Inc.?

Yes. Compass Therapeutics, Inc. trades publicly on NASDAQ as CMPX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Compass Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.